Hasil Pencarian - Philippe Gabriel Steg

Perbaiki Hasil
  1. 1
    Direct-acting Anticoagulants in Chronic Coronary Syndromes

    Direct-acting Anticoagulants in Chronic Coronary Syndromes oleh Emmanuel Sorbets, Philippe Gabriel Steg

    Diterbitkan 2020-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    On the use of propensity scores in case of rare exposure

    On the use of propensity scores in case of rare exposure oleh David Hajage, Florence Tubach, Philippe Gabriel Steg, Deepak L. Bhatt, Yann De Rycke

    Diterbitkan 2016-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Cangrelor: Clinical Data, Contemporary Use, and Future Perspectives

    Cangrelor: Clinical Data, Contemporary Use, and Future Perspectives oleh Leonardo De Luca, Philippe Gabriel Steg, Deepak L. Bhatt, Davide Capodanno, Dominick J. Angiolillo

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Delphi-consensus weights for ischemic and bleeding events to be included in a composite outcome for RCTs in thrombosis prevention.

    Delphi-consensus weights for ischemic and bleeding events to be included in a composite outcome for RCTs in thrombosis prevention. oleh Agnes Dechartres, Pierre Albaladejo, Jean Mantz, Charles Marc Samama, Jean-Philippe Collet, Philippe Gabriel Steg, Philippe Ravaud, Florence Tubach

    Diterbitkan 2011-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Assessment of real-time electrocardiogram effects on interpretation quality by emergency physicians

    Assessment of real-time electrocardiogram effects on interpretation quality by emergency physicians oleh Alice Perrichot, Pradeebane Vaittinada Ayar, Pierre Taboulet, Christophe Choquet, Matthieu Gay, Enrique Casalino, Philippe Gabriel Steg, Sonja Curac, Prabakar Vaittinada Ayar

    Diterbitkan 2023-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Management of coronary artery disease patients in Latvia compared with practice in Central-Eastern Europe and globally: Analysis of the CLARIFY registry

    Management of coronary artery disease patients in Latvia compared with practice in Central-Eastern Europe and globally: Analysis of the CLARIFY registry oleh Andrejs Erglis, Iveta Mintale, Gustavs Latkovskis, Inga Balode, Sanda Jegere, Iveta Bajare, Aldis Rozenbergs, Nicola Greenlaw, Roberto Ferrari, Philippe Gabriel Steg

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Atrial Fibrillation Management Strategies in Routine Clinical Practice: Insights from the International RealiseAF Survey.

    Atrial Fibrillation Management Strategies in Routine Clinical Practice: Insights from the International RealiseAF Survey. oleh Chern-En Chiang, Lisa Naditch-Brûlé, Sandrine Brette, José Silva-Cardoso, Habib Gamra, Jan Murin, Oleg J Zharinov, Philippe Gabriel Steg

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Insufficient control of heart rate in stable coronary artery disease patients in Latvia

    Insufficient control of heart rate in stable coronary artery disease patients in Latvia oleh Inga Balode, Iveta Mintāle, Gustavs Latkovskis, Sanda Jēgere, Inga Narbute, Iveta Bajāre, Nicola Greenlaw, Philippe Gabriel Steg, Roberto Ferrari, Andrejs Ērglis

    Diterbitkan 2014-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Effect of proprotein convertase subtilisin/kexin type 9 inhibition on cancer events: A pooled, post hoc, competing risk analysis of alirocumab clinical trials

    Effect of proprotein convertase subtilisin/kexin type 9 inhibition on cancer events: A pooled, post hoc, competing risk analysis of alirocumab clinical trials oleh Kusha A. Mohammadi, Taylor Brackin, Gregory G. Schwartz, Philippe Gabriel Steg, Michael Szarek, Garen Manvelian, Robert Pordy, Sergio Fazio, Gregory P. Geba

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Prevalence, treatment and determinants of obstructive sleep apnoea and its symptoms in a population-based French cohort

    Prevalence, treatment and determinants of obstructive sleep apnoea and its symptoms in a population-based French cohort oleh Pauline Balagny, Emmanuelle Vidal-Petiot, Adeline Renuy, Joane Matta, Justine Frija-Masson, Philippe Gabriel Steg, Marcel Goldberg, Marie Zins, Marie-Pia d'Ortho, Emmanuel Wiernik

    Diterbitkan 2023-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Late Intervention on an Occluded Infarct-Related Artery: A Meta-analysis of the Randomized Controlled Trials

    Late Intervention on an Occluded Infarct-Related Artery: A Meta-analysis of the Randomized Controlled Trials oleh Axel Zagler, Todd B. Heimowitz, Esteban Escolar, Steven J. Hussein, Zaheer R. Yousef, Philippe Gabriel Steg, Vladimir Dzavik, Judith S. Hochman, Paul A. Vignola, Gervasio A. Lamas

    Diterbitkan 2007-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Epicardial adipose tissue thickness correlates with the presence and severity of angiographic coronary artery disease in stable patients with chest pain.

    Epicardial adipose tissue thickness correlates with the presence and severity of angiographic coronary artery disease in stable patients with chest pain. oleh Fabien A Picard, Pascal Gueret, Jean-Pierre Laissy, Stéphane Champagne, Florence Leclercq, Didier Carrié, Jean-Michel Juliard, Patrick Henry, Ralph Niarra, Gilles Chatellier, Philippe Gabriel Steg

    Diterbitkan 2014-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Inflammatory Biomarkers Interleukin‐6 and C‐Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial

    Inflammatory Biomarkers Interleukin‐6 and C‐Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque... oleh Claes Held, Harvey D. White, Ralph A. H. Stewart, Andrzej Budaj, Christopher P. Cannon, Judith S. Hochman, Wolfgang Koenig, Agneta Siegbahn, Philippe Gabriel Steg, Joseph Soffer, W. Douglas Weaver, Ollie Östlund, Lars Wallentin

    Diterbitkan 2017-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding

    Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding oleh Daniel Lindholm, Emil Hagström, Stefan K. James, Richard C. Becker, Christopher P. Cannon, Anders Himmelmann, Hugo A. Katus, Gerald Maurer, José Luis López‐Sendón, Philippe Gabriel Steg, Robert F. Storey, Agneta Siegbahn, Lars Wallentin

    Diterbitkan 2017-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Double‐Dose Versus Standard‐Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

    Double‐Dose Versus Standard‐Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention oleh Matthias Bossard, Christopher B. Granger, Jean‐Francois Tanguay, Gilles Montalescot, David P. Faxon, Sanjit S. Jolly, Petr Widimsky, Kari Niemela, Philippe Gabriel Steg, Madhu K. Natarajan, Peggy Gao, Keith A. A. Fox, Salim Yusuf, Shamir R. Mehta

    Diterbitkan 2017-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Long‐Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5 Years of Placebo‐Controlled Observation in the ODYSSEY OUTCOMES Trial

    Long‐Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5 Years of Placebo‐Controlled Observation in the ODYSSEY OUTCOMES Trial oleh Shaun G. Goodman, Philippe Gabriel Steg, Yann Poulouin, Deepak L. Bhatt, Vera A. Bittner, Rafael Diaz, Genevieve Garon, Robert A. Harrington, J. Wouter Jukema, Garen Manvelian, Wanda Stipek, Michael Szarek, Harvey D. White, Gregory G. Schwartz

    Diterbitkan 2023-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Efficacy and Safety of Ticagrelor Monotherapy by Clinical Presentation: Pre‐Specified Analysis of the GLOBAL LEADERS Trial

    Efficacy and Safety of Ticagrelor Monotherapy by Clinical Presentation: Pre‐Specified Analysis of the GLOBAL LEADERS Trial oleh Pascal Vranckx, Marco Valgimigli, Ayodele Odutayo, Patrick W. Serruys, Christian Hamm, Philippe Gabriel Steg, Dik Heg, Eugene P. Mc Fadden, Yoshinobu Onuma, Edouard Benit, Luc Janssens, Roberto Diletti, Maurizio Ferrario, Kurt Huber, Lorenz Räber, Stephan Windecker, Peter Jüni

    Diterbitkan 2021-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Benefit–Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness

    Benefit–Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness oleh Gary E. Raskob, Walter Ageno, Gregory Albers, C. Gregory Elliott, Jonathan Halperin, Gregory Maynard, Philippe Gabriel Steg, Jeffrey I. Weitz, John Albanese, Zhong Yuan, Bennett Levitan, Wentao Lu, Eun Young Suh, Theodore Spiro, Concetta Lipardi, Elliot S. Barnathan, Alex C. Spyropoulos

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial

    Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial oleh Chao Gao, Mariusz Tomaniak, Kuniaki Takahashi, Hideyuki Kawashima, Rutao Wang, Hironori Hara, Masafumi Ono, Gilles Montalescot, Scot Garg, Michael Haude, Ton Slagboom, Pascal Vranckx, Marco Valgimigli, Stephan Windecker, Robert-Jan van Geuns, Christian Hamm, Philippe Gabriel Steg, Yoshinobu Onuma, Dominick J. Angiolillo, Patrick W. Serruys

    Diterbitkan 2020-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Self‐Reported Health and Outcomes in Patients With Stable Coronary Heart Disease

    Self‐Reported Health and Outcomes in Patients With Stable Coronary Heart Disease oleh Ralph A. H. Stewart, Emil Hagström, Claes Held, Tom Kai Ming Wang, Paul W. Armstrong, Philip E. Aylward, Christopher P. Cannon, Wolfgang Koenig, José Luis López‐Sendón, Emile R. Mohler, Nermin Hadziosmanovic, Susan Krug‐Gourley, Marco Antonio Ramos Corrales, Saulat Siddique, Philippe Gabriel Steg, Harvey D. White, Lars Wallentin

    Diterbitkan 2017-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: